Turbulent mixing and the formation of an intermediate nepheloid layer above the Siberian continental shelf break

Intermediate nepheloid layers (INLs) form important pathways for the cross-slope transport and vertical export of particulate matter, including carbon. While intermediate maxima in particle settling fluxes have been reported in the Eurasian Basin of the Arctic Ocean, direct observations of turbid INLs above the continental slope are still lacking. In this study, we provide the first direct evidence of an INL, coinciding with enhanced mid-water turbulent dissipation rates, over the Laptev Sea continental slope in summer 2018. Current velocity data show a period of enhanced downslope flow with depressed isopcynals, suggesting that the enhanced turbulent dissipation is probably the consequence of the presence of an unsteady lee wave. Similar events occur mostly during ice free periods, suggesting an increasing frequency of episodic cross-slope particle transport in the future. The discovery of the INL and the episodic generation mechanism provide new insights into particle transport dynamics in this rapidly changing environment

Intrahepatic cholangiocarcinoma: current perspectives

Intrahepatic cholangiocarcinoma (ICC) is the second most common malignancy arising from the liver. ICC makes up about 10% of all cholangiocarcinomas. It arises from the peripheral bile ducts within the liver parenchyma, proximal to the secondary biliary radicals. Histologically, the majority of ICCs are adenocarcinomas. Only a minority of patients (15%) present with resectable disease, with a median survival of less than 3 years. Multidisciplinary management of ICC is complicated by large differences in disease course for individual patients both across and within tumor stages. Risk models and nomograms have been developed to more accurately predict survival of individual patients based on clinical parameters. Predictive risk factors are necessary to improve patient selection for systemic treatments. Molecular differences between tumors, such as in the epidermal growth factor receptor status, are promising, but their clinical applicability should be validated. For patients with locally advanced disease, several treatment strategies are being evaluated. Both hepatic arterial infusion chemotherapy with floxuridine and yttrium-90 embolization aim to downstage locally advanced ICC. Selected patients have resectable disease after downstaging, and other patients might benefit because of postponing widespread dissemination and biliary obstruction